GB8906796D0 - Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions - Google Patents
Method of enhancing neutralising antibody activity in human or animal sera or in other body secretionsInfo
- Publication number
- GB8906796D0 GB8906796D0 GB898906796A GB8906796A GB8906796D0 GB 8906796 D0 GB8906796 D0 GB 8906796D0 GB 898906796 A GB898906796 A GB 898906796A GB 8906796 A GB8906796 A GB 8906796A GB 8906796 D0 GB8906796 D0 GB 8906796D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- enhancing
- human
- antibody activity
- neutralising antibody
- body secretions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Neutralising antibody activity is enhanced by exposure of the antibody to an enhancing factor comprising or extracted from human or animal saliva or an enzyme for the digestion of carbohydrates which is not inimical to the neutralising antibody, for example amylase or lysozyme, in an antibody activity enhancing amount.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898906796A GB8906796D0 (en) | 1989-03-23 | 1989-03-23 | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions |
GB9006608A GB2229725B (en) | 1989-03-23 | 1990-03-23 | A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898906796A GB8906796D0 (en) | 1989-03-23 | 1989-03-23 | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8906796D0 true GB8906796D0 (en) | 1989-05-10 |
Family
ID=10653944
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB898906796A Pending GB8906796D0 (en) | 1989-03-23 | 1989-03-23 | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions |
GB9006608A Expired - Fee Related GB2229725B (en) | 1989-03-23 | 1990-03-23 | A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9006608A Expired - Fee Related GB2229725B (en) | 1989-03-23 | 1990-03-23 | A method of enhancing neutralising antibody activity in human or animal sera or in other body secreations |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB8906796D0 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE476199T1 (en) | 2003-01-16 | 2010-08-15 | Pedersen Medical As | ANTIMICROBIAL COMPOSITION FOR TOPICAL USE ON THE MUCOSA AND SKIN |
-
1989
- 1989-03-23 GB GB898906796A patent/GB8906796D0/en active Pending
-
1990
- 1990-03-23 GB GB9006608A patent/GB2229725B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2229725A (en) | 1990-10-03 |
GB9006608D0 (en) | 1990-05-23 |
GB2229725B (en) | 1993-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR12C0004I2 (en) | ANTIBODIES TO HUMAN CTLA-4 ANTIGEN AND USE | |
EP0365685A4 (en) | Freeze-dried composition containing enzyme-labeled antihuman interferon-_g(b) antibody and enzymatic immunoassay kit containing the composition | |
HU892558D0 (en) | Process and preparation for the induction of a joint | |
DK0909388T3 (en) | Immunological assay for spongiform encephalopathies | |
EP0204989A3 (en) | Use of penicillamine in the treatment of immune deficiency diseases | |
PH31198A (en) | Protein recognized by antibodies raised against native P28 of schitosoma mansoni. | |
GB8906796D0 (en) | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions | |
FI881122A (en) | Method for isolating basement membrane proteins from human and animal tissues | |
SE9903534L (en) | Carrier containing a major capsid protein L1 from human papillomavirus and its use | |
JPS5615215A (en) | Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel | |
GR3006794T3 (en) | ||
GB2003887A (en) | Isolation of peptides from urine | |
DE69027441D1 (en) | Ribozymenhemmer | |
AU1948788A (en) | Expression of immunologically active proteins of human b-lymphotropic virus | |
AU590712B2 (en) | Immune interferon and method for its purification | |
GR3015489T3 (en) | Monoclonal antibodies and process for the diagnosis of phytophtora infections. | |
SE8306384L (en) | PHARMACEUTICAL COMPOSITION | |
SE8500340D0 (en) | ANTIBODY PREPARATION AND WAY TO PREPARE AND SET TO USE IT | |
TW221711B (en) | N-AFP monoclonal antibody and method of preparation thereof |